Lasers | Ophthalmology Innovation Source

Second Acts – Reinventing Your Company

Building a successful biotech or biopharma company typically turns on a sentinel event – the pivot, as William J. Link, PhD, Managing Director of Versant Ventures calls it. That can involve a complete shift in a company’s focus. Link hosted a panel at the Ophthalmology Innovation Summit in Chicago, where CEOs and founders explained how…

InnFocus

InnFocus Inc.’s MicroShunt glaucoma drainage implant is designed to reduce intraocular pressure in glaucoma patients. President and CEO Russell Trenary explained that the implant is made from a revolutionary and highly biocompatible material that is ultra-stable and does not degrade. In the past year, InnFocus has been conducting the first randomized controlled study against trabeculectomy,…

IOPtima

Ronen Castro, CEO of Israeli company IOPtima Ltd., introduced the CLASS (CO2 Laser-Assisted Sclerectomy Surgery) procedure for glaucoma, which has results comparable to trabeculectomy, but is non-invasive. This was the company’s first year for commercial activity. In March it secured CFDA approval in China, and in the fourth quarter of this year it begins initial…

WaveTec Vision Systems

WaveTec Vision Systems ORA system is the first intra-operative diagnostic tool on the market to enhance visual outcomes in cataract surgery. It allows surgeons, in real-time, to see incisions and intraocular lens (IOL) alignment to support optimal IOL positioning. Thomas G. Frinzi, the company’s President and CEO, announced to OIS attendees that WaveTec’s acquisition by…

CEOs Share Their ‘Second Acts’ On Way to Building Successful Companies

Building a successful biotech or biopharma company typically turns on a sentinel event — the pivot, as William J. Link, PhD, Managing Director of Versant Ventures calls it. That can involve a complete shift in a company’s focus. Link hosted a panel at the Ophthalmology Innovation Summit in Chicago, where CEOs and founders explained how…

Donnenfeld Bullish on Ophthalmic Innovation

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 003″] Eric Donnenfeld, MD, former president of ASCRS, explains technology has profoundly changed how ophthalmology is delivered. He also shares some of his priority issues while he was president of the ASCRS including training the next generation of ophthalmic surgeons. Podcast Guest Eric Donnenfeld Dr. Donnenfeld is a Clinical Professor of…

WaveTec Vision Systems

WaveTec Vision® Systems, Inc. is a privately-held ophthalmic medical device company and is the proven leader in intraoperative wavefront technology. The company is focused on research, development, manufacturing, and distribution of the ORA System® with VerifEye™ (Optiwave® Refractive Analysis) used during cataract surgery. WaveTec’s ORA System’s streaming refractive information, affordable pricing model, practice support program,…

2014 Ophthalmology Innovator Award Presentation

Gil Kliman presents the 2014 Ophthalmology Innovator Award to Mark Forchette, President & CEO of OptiMedica. OptiMedica, with Mark at the helm, is leading the way to developing a entire new market in ophthalmology for femtosecond lasers. Listen to Gil interview Mark on how he got to where he is today. Presenter: Gilbert H. Kliman,…

NexisVision Pivots to Develop a Novel Contact Lens Technology

Formed in 2008 NexisVision’s initial target was next generation corneal refractive surgery or in other words, the comfort and function of LASIK without a flap. In the last 18-24 months the company has pivoted to develop a novel contact lens technology. Presenter: Marguerite McDonald, MD Marguerite McDonald, MD, FACS, is a board-certified ophthalmologist offering corneal,…

Funding Ophthalmology Innovation: The Focus of Science and Capital

Ophthalmology is a growing, but challenging, market. Innovation is abounding in its research stages and some people in the know foresee more positive development in breakthrough technologies by 2020, while delivering drugs to the back of the eye is up front in the minds and agendas of investors and innovators. Market data and dialogue indicate…

FDA Focus on More Efficient Processing Yields Faster Decisions

SAN FRANCISCO — The U.S. Food and Drug Administration has been criticized for its ponderous movement of potential drugs and medical devices through the approval process. Recognizing this criticism, and following implementation of the Medical Devices User Fee and Modernization Act of 2002 and subsequent internal reevaluations and reorganizations, the FDA approval process for innovative…